NewGenIvf Group Limited (NIVF) Stock Forecast
NIVF analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $508.32 average of analyst targets
- Upside to target
- +182,093.6% from the latest close
- Next earnings
- —
- 52-week range
- $0.20 – $2,825.28
NIVF price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
NIVF earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current fiscal year (2026) | $170.64 | $170.64 | $170.64 | −$8,761.98 | +102.0% | 1 |
| Next fiscal year (2027) | $336.24 | $336.24 | $336.24 | $170.64 | +97.0% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
NIVF revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | — | — |
| Current fiscal year (2026) | $65.1M | $65.1M | $65.1M | +1,277.4% | 1 |
| Next fiscal year (2027) | $180.4M | $180.4M | $180.4M | +177.1% | 1 |
NIVF EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
NIVF revenue: reported and forecast
NIVF EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current fiscal year (2026) | $3,434.40 | $170.64 | $170.64 | $170.64 | $170.64 | −95.0% | 0 up · 0 down |
| Next fiscal year (2027) | $13,716.00 | $336.24 | $336.24 | $336.24 | $336.24 | −97.5% | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
NIVF earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; NIVF beat in 2 of 2.
What analysts expect from NIVF
The average price target is $508.32, 182,093.6% above the latest close of $0.28. Analysts expect earnings of $170.64 per share for 2026, +102.0% from a year earlier. For 2027 the average estimate is $336.24 per share on revenue of $180.4 million. NewGenIvf beat the EPS estimate in 2 of the last 2 quarters.
Related: NIVF income statement, NIVF key metrics, NIVF chart. See the NIVF stock overview for the latest quote and news.
NIVF forecast FAQ
What is NewGenIvf's price target?
The average analyst price target for NewGenIvf is $508.32, 182,093.6% above the latest close of $0.28.
What is NewGenIvf's EPS forecast?
Analysts forecast $170.64 per share for 2026 (range $170.64 to $170.64); for 2027 the estimate is $336.24.
What is NewGenIvf's revenue forecast?
The average revenue estimate for 2026 is $65.1 million, growth of 1,277.4%; for 2027 it is $180.4 million.
Does NewGenIvf usually beat earnings estimates?
NewGenIvf reported EPS at or above the analyst estimate in 2 of the last 2 quarters.